In summary, Q-1 can significantly alleviate RA in rats by downregulating the expressions of IκB, P-IκB, P65, and P-P65, in the synovial tissues, inhibiting the excessive release of inflammatory factors, and inhibiting the excessive activation of the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is rheumatoid arthritis.